Prescription drug · NDA
Journavx (Suzetrigine) NDC 51167-548
Suzetrigine 50 mg/1 · Tablet, Film coated · Oral · Vertex Pharmaceuticals Incorporated
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 51167-548-25 | 51167054825 | 5 BLISTER PACK in 1 CARTON (51167-548-25) / 5 TABLET, FILM COATED in 1 BLISTER PACK (51167-548-05)Marketed from Jan 30, 2025 · Sample package | |
| 51167-548-30 | 51167054830 | 30 TABLET, FILM COATED in 1 BOTTLE (51167-548-30)Marketed from Jan 30, 2025 | |
| 51167-548-31 | 51167054831 | 100 TABLET, FILM COATED in 1 BOTTLE (51167-548-31)Marketed from Jan 30, 2025 | |
| 51167-548-34 | 51167054834 | 10 BLISTER PACK in 1 CARTON (51167-548-34) / 10 TABLET, FILM COATED in 1 BLISTER PACKMarketed from Jan 30, 2025 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Journavx
- Generic name (nonproprietary)
- suzetrigine
- Active ingredients
- Suzetrigine — 50 mg/1
- Dosage form
- Tablet, Film coated
- Route
- Oral
- Labeler
- Vertex Pharmaceuticals IncorporatedNDC labeler code 51167
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 219209
- Marketing start
- Listing expires
- Other FDA classes
- Cytochrome P450 3A Inducers (Mechanism)Sodium Channel Antagonists (Mechanism)
- Identifiers
- Product ID 51167-548_6af8a930-2a29-428c-96da-94045a1f7d4eSPL ID 6af8a930-2a29-428c-96da-94045a1f7d4eSPL set ID f0976da4-1d20-4517-945c-b60ed2f41c12RxCUI 2704833, 2704839UNII LOG73M21H5UPC 0351167548301, 0351167548318
- Pharmacologic class
- Sodium Channel Blocker
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N451167054825followed by a unit qualifier and the quantityPackage 51167-0548-25. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
JOURNAVX is indicated for the treatment of moderate to severe acute pain, including postoperative pain, in adults. JOURNAVX is a sodium channel blocker indicated for the treatment of moderate to severe acute pain, including postoperative pain, in adults. ( 1 )
Excerpt only. Read the full label for complete information.
About NDC 51167-548
- What is NDC 51167-548?
- 51167-548 is the product NDC for Journavx (suzetrigine), Suzetrigine 50 mg/1 tablet, film coated, listed with the FDA by Vertex Pharmaceuticals Incorporated. It has 4 package NDCs, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Journavx (Suzetrigine).
- What is the active ingredient?
- Suzetrigine.
- Who is the labeler?
- Vertex Pharmaceuticals Incorporated, NDC labeler code 51167. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Journavx?
- 1 other product NDC are listed under this name. See all Journavx NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Journavx products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Journavxsuzetrigine | Suzetrigine 50 mg/1 | Tablet, Film coatedOral | Sportpharm LLC | 85766-243 | 85766-0243-0185766-0243-2085766-0243-30+1 more |
Other NDCs under NDA 219209
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Journavxsuzetrigine | Suzetrigine 50 mg/1 | Tablet, Film coatedOral | Sportpharm LLC | 85766-243 |